Changes in total serum glycosaminoglycan levels in patients undergoing renal transplantation: Preliminary data

Surgery Today

Volumn 34, Issue 8, 2004, Pages 668-672

  Papaioannou, Eleni G ^a   Magkou, Christina ^a   Kostakis, Alkiviadis ^b   Staikou, Chryssoula ^b   Mitsoula, Panagiota ^b   Kyriakides, Stylianos ^b   Sitaras, Nikolaos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

Glycosaminoglycans; Graft rejection; Hemodialysis; Renal transplantation

Indexed keywords

CREATININE; GLYCOSAMINOGLYCAN;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; KIDNEY TRANSPLANTATION; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; UREA NITROGEN BLOOD LEVEL;

EID: 4043141492     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-004-2795-4     Document Type: Article

References (28)

1. Laurent TC, Laurent UBG, Fraser RE. Serum hyaluronan as a disease marker. Ann Med 1996;28:241-53.
2. Engstrom-Laurent A. Changes in hyaluronan concentration in tissues and body fluids in disease states. Ciba Found Symp 1989;143:233-40.
3. Hansen C, Otto E, Kuhlemann K, Forster G, Kahaly GJ. Glycosaminoglycans in autoimmunity. Clin Exp Rheumatol 1996; 14(suppl 15):S59-67.
4. Nietfeld JJ. Cytokines and proteoglycans. Experientia 1993;49: 456-69.
5. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991;71:481-539.
6. Wells A, Larsson E, Hanas E, Laurent T, Hallgren R, Tufveson G. Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 1993;55:1346-9.
7. Rodriguez-Cuartero A, Perez-Blanco FJ, Campos-Gonzalez M, Vicente FJ, Tallada A. Urinary excretion of glycosaminoglycans in patients with a renal transplant. Clin Nephrol 1997;472:274-6.
8. Carney LS. Proteoglycans. In: Chaplin MF, Kennedy JF, editors. Carbohydrate analysis: a practical approach. Oxford: Oxford University Press; 1987. p. 97-142.
9. Bitter-Muir H. A modified uronic acid carbazole reaction. Anal Biochem 1962;4:330-4.
10. Tencer J, Torffvit O, Bjornsson S, Thysell H, Grubb A, Rippe B. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases. Clin Nephrol 1997;48:212-9.
11. Yokohama H, Sato K, Okudaira M, Morita C, Takahashi C, Suzuki D, et al. Serum and urinary concentrations of heparane sulfate in patients with diabetic nephropathy. Kidney Int 1999; 56:650-8.
12. Davies M. Glomerular cell proteoglycans: their possible role in progressive glomerular disease. Exp Nephrol 1995;3:122-6.
13. Stenvinkel P, Heimburger O, Wang T, Lindholm B, Bergstrom J, Elinder CG. High serum hyaluronan indicates poor survival in renal replacement therapy. Am J Kidney Dis 1999;34:1083-8.
14. de Medina M, Ashby M, Diego J, Pennell JP, Hill M, Schiff ER, et al. Factors that influence serum hyaluronan levels in hemodialysis patients. ASAIO J 1999;45:428-30.
15. Stefanidis I, Heintz B, Stocker G, Mrowka C, Sieberth HG, Haubeck HD. Association between heparan sulfate proteoglycan excretion and proteinuria after renal transplantion. J Am Soc Nephrol 1996;7:2670-6.
16. Soejima Y, Yanaga K, Wakiyama S, Nishizaki T, Yoshizumi T, Sugimachi K. Serum hyaluronic acid as a reliable parameter of allograft viability in porcine liver transplantation. Hepatogastroenterology 1996;43:590-5.
17. Mitchell L, Superina R, Delorme M, Vegh P, Berry L, Hoogendoorn H, et al. Circulating dermatan sulfate and heparan sulfate/heparin proteoglycans in children undergoing liver transplantation. Thromb Haemost 1995;74:859-63.
18. Itasaka H, Kishikawa K, Suehiro T, Yanaga K, Shimada M, Higashi H, et al. Serum hyaluronic acid for the assessment of graft viability in porcine liver transplantation. Surg Today 1994;24:719-24.
19. Turney JH, Davison AM, Forbes MA, Cooper EH. Hyaluronic acid in end-stage renal failure treated by haemodialysis: clinical correlates and implications. Nephrol Dial Transplant 1991;6:566-70.
20. Blancho G, Gianello PR, Lorf T, Germana S, Giangrande I, Mourad G, et al. Molecular and cellular events implicated in local tolerance to kidney allografts in miniature swine. Transplantation 1997;63:26-33.
21. Batten P, Yacoub MN, Rose ML. Effect of human cytokines (IFN-γ, TNF-α, IL-1β, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. Immunology 1996;87:127-133.
22. Galante NZ, Tedesco HS, Machado PG, Pacheco-Silva A, Medina-Pestana JO. Acute rejection is a risk factor for long-term survival in a single-center analysis of 1544 renal transplants. Transplant Proc 2002;34:508-13.
23. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002;13: 779-87.
24. Moon JI, Kim YS, Chung SY, Kim MS, Kim SI, Park K. Long-term results of kidney transplantation between HLA-identical siblings. Surg Today 2001;31:123-8.
25. Shmizu S, Ueda M, Ozawa S, Wakabayashi G, Endo M, Hayakawa K, et al. Detection of IL-2 receptor gene expression in peripheral blood from renal transplant patients. Surg Today 2001;31:1058-64.
26. Hallgren R, Gerdin B, Tufveson G. Hyaluronic acid accumulation and redistribution in rejecting kidney graft. Relationship to the transplantation edema. J Exp Med 1990;171:2063-76.
27. Hallgren R, Engstrom-Laurent A, Nisbeth U. Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uremia. Nephron 1987;46:150-4.
28. Koshiishi I, Hasegawa T, Imanari T. Quantitative and qualitative alterations of chondroitin/dermatan sulfates accompanied with development of tubulointerstitial nephritis. Arch Biochem Biophys 2002;401:38-43.